large_latest_news_sunglasses_on_pile_of_documents_d3dbb91d65.jpg

medium_latest_news_sunglasses_on_pile_of_documents_d3dbb91d65.jpg

small_latest_news_sunglasses_on_pile_of_documents_d3dbb91d65.jpg

thumbnail_latest_news_sunglasses_on_pile_of_documents_d3dbb91d65.jpg

news

LATEST NEWS

Cele mai recente știri

The countries in this region are our traditional export markets because they have known our products for 85 years. We also export to the European Union, Russia and CIS, North America, and some countries in the Middle East. We have also added Canada, Italy, Austria, Spain, Portugal, and Saudi Arabia to our list of new markets in the past several years.

Interview of the CEO / President of the Management Board of Alkaloid AD Skopje for the Serbian magazine “Magazin Biznis”

Interview of the CEO / President of the Management Board of Alkaloid AD Skopje for the Serbian magazine “Nedeljnik”

Interview of the CEO / President of the Management Board of Alkaloid AD Skopje for the business magazine "Economy and Business"

Interview of the CEO / President of the Management Board of Alkaloid AD Skopje for AmCham

Statement of the CEO / President of the Management Board of Alkaloid AD Skopje for N1 Serbia

"Path to success" Interview of the CEO / President of the Management Board of Alkaloid AD Skopje, Zhivko Mukaetov

OTHER NEWS

VIDEO GALLERY

Facebook

Youtube

Instagram

Media Centar

News

thumbnail_Group 642.png

Group 642.png

As the holder of the first international value-added medicine patent – liquid&nbsp;Omeprazole, ready to use – Alkaloid sponsored the First International Conference on Modern Approaches to GERD Treatment in Pediatric Patients, held in Zagreb, Croatia.

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE: FIRST INTERNATIONAL CONFERENCE ON INNOVATIVE SOLUTIONS IN PEDIATRIC GERD TREATMENT HELD IN ZAGREB

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE

ALKALOID AD Skopje 2025 BUSINESS PLAN - SUMMARY

ALKALOID AD Skopje honored with four awards: Most Transparent Listed Joint Stock Company selected by the media and by market participants, Stock of the Year, and Good ESG Practices

Generic pharmaceutical companies, such as Alkaloid, are essential partners of healthcare systems, ensuring a reliable and sustainable supply of premium-quality pharmaceutical products at affordable prices.

ZHIVKO MUKAETOV – PANELIST AT THE 3RD AMCHAM HEALTHCARE CONFERENCE

Nearly 100 of the 124 first-year students enrolled in the Master of Pharmacy program at the Faculty of Pharmacy at Ss. Cyril and Methodius University in Skopje (UKIM), attended the lecture titled The Pharmaceutical Industry – Challenges and Trends, delivered at the faculty by Mr. Zhivko Mukaetov, CEO and MB President of Alkaloid AD Skopje.

Alkaloid’s Success Story – Shared with New Pharmacy Students at UKIM

ALKALOID reached consolidated sales of EUR 231.3 million, consolidated export of EUR 157.7 million and invested EUR 16.5 million in the January – September 2024 period.

ALKALOID – operating results for the January – September 2024 period

ALKALOID AD Skopje invests in South Korean research and development company

To fully integrate all laboratory processes, centralize the management of data and processes, ensure their traceability for product control, maintain regulatory compliance, and support continuous advancement, the company has begun implementing the AlkaLIMS software platform.

ALKALOID TAKES A STEP FURTHER TOWARD COMPLETE DIGITALIZATION

ALKALOID HOLDS FIRST LEADERSHIP DEVELOPMENT EVENT

ALKALOID AD Skopje Registers New Company in Kazakhstan

ALKALOID reached consolidated sales of EUR 153.9 million, consolidated export of EUR 106.9 million and invested EUR 11 million in the period January - June 2024.

ALKALOID – operating results for the January – June 2024 period

Since it was first established back in August 1936, Alkaloid has grown and developed through very tumultuous and challenging decades to become the modern, export-oriented company with nearly 3,000 employees that it is today.

Our Brands are Part of People’s Lives - interview of the CEO / MB President of Alkaloid AD Skopje, Zhivko Mukaetov, for The Region magazine

Alkaloid - awarded 2023 Patent of the Year for groundbreaking liquid Omeprazole

"1st Cefixime Global Meeting" in Istanbul, supported by Alkaloid

ADDRESS OF THE CEO/MB PRESIDENT OF ALKALOID AD SKOPJE

Address of the CEO

Alkaloid AD Skopje relies on the highest ethical norms and standards when doing business. We are sure that the ethical conduct of business is a prerequisite for lasting personal and professional success. Our key values are:&nbsp;

OUR CORE VALUES

Our values

Visit your local Alkaloid website

Serbia

Romania

CIS

Croatia

Ukraine

Bulgaria

Bosnia and Herzegovina